Within its last year performance, KRON fell by -22.29%, with highs and lows ranging from $2.29 to $0.73, whereas the simple moving average fell by -4.09% in the last 200 days.
On September 14, 2022, Berenberg started tracking Kronos Bio Inc (NASDAQ: KRON) recommending Buy. H.C. Wainwright also rated KRON shares as ‘Buy’, setting a target price of $35 on the company’s shares in an initiating report dated June 24, 2021. Piper Sandler Initiated an Overweight rating on November 03, 2020, and assigned a price target of $50. Jefferies initiated its ‘Buy’ rating for KRON, as published in its report on November 03, 2020. Goldman’s report from November 03, 2020 suggests a price prediction of $45 for KRON shares, giving the stock a ‘Buy’ rating. Cowen also rated the stock as ‘Outperform’.
Analysis of Kronos Bio Inc (KRON)
One of the most important indicators of Kronos Bio Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -53.39% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.46, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and KRON is recording 246.42K average volume. On a monthly basis, the volatility of the stock is set at 11.96%, whereas on a weekly basis, it is put at 13.31%, with a gain of 26.47% over the past seven days. Furthermore, long-term investors anticipate a median target price of $4.25, showing growth from the present price of $1.29, which can serve as yet another indication of whether KRON is worth investing in or should be passed over.
How Do You Analyze Kronos Bio Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 34.34%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 32.06% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
KRON shares are owned by institutional investors to the tune of 32.06% at present.
